Thursday, September 29, 2022
Home Tags IQVIA


IQVIA study: Most prescription costs down, but seniors paying more

The report determined that 90% of all patients pay less than $500 in out-of-pocket costs on an annual basis.

Danbury’s IQVIA teams with JDRF on diabetes research project

Roughly 40% of people with adult-onset type 1 diabetes may be initially misdiagnosed.

Danbury’s IQVIA creates matching tool for COVID-19 trials

The new tool will be accessible at c19trials.com.

Danbury’s IQVIA debuts Avacare Clinical Research Network

Avacare will provide coverage across 19 therapeutic areas and on behalf of 6.5 million patients.

IQVIA of Danbury debuts FluSTAR app for tracking flu and cold...

The app updates flu and cold-related illnesses data for every ZIP code in the country.

CT opioid prescriptions down – but related deaths up

Connecticut's opioid-prescription rate fell by more than the national average from 2013 to 2017.

QuintilesIMS changes name to IQVIA

The Danbury company recently posted third-quarter revenue of $2 billion, a 4.8 percent increase over the previous third quarter.